全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Advances in Identifying Beryllium Sensitization and Disease

DOI: 10.3390/ijerph7010115

Keywords: beryllium, BeLPT, beryllium sensitization, BeS, screening, chronic beryllium disease, CBD

Full-Text   Cite this paper   Add to My Lib

Abstract:

Beryllium is a lightweight metal with unique qualities related to stiffness, corrosion resistance, and conductivity. While there are many useful applications, researchers in the 1930s and l940s linked beryllium exposure to a progressive occupational lung disease. Acute beryllium disease is a pulmonary irritant response to high exposure levels, whereas chronic beryllium disease (CBD) typically results from a hypersensitivity response to lower exposure levels. A blood test, the beryllium lymphocyte proliferation test (BeLPT), was an important advance in identifying individuals who are sensitized to beryllium (BeS) and thus at risk for developing CBD. While there is no true "gold standard" for BeS, basic epidemiologic concepts have been used to advance our understanding of the different screening algorithms.

References

[1]  Cunningham, LD. Beryllium Recycling in the United States in 2000.
[2]  Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Beryllium.
[3]  Gelman, I. Poisoning by vapors of beryllium oxyfluoride. J. Indust. Hyg. Toxicol.?1936, 18, 371–379.
[4]  Cummings, KJ; Stefaniak, AB; Virji, MA; Kreiss, K. A reconsideration of acute beryllium disease. Environ. Health Perspect.?2009, 117, 1250–1256.
[5]  Sprince, NL. Beryllium disease. In Occupational Respiratory Diseases; Merchant, JA, Ed.; National Institute for Occupational Safety and Health: Washington, DC, USA, 1986; pp. 385–399.
[6]  Middleton, DC. Chronic beryllium disease: Uncommon disease, less common diagnosis. Environ. Health Perspect.?1998, 106, 765–767.
[7]  Newman, LS; Kreiss, K; King, TE; Seay, S; Campbell, PA. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am. Rev. Respir. Dis.?1989, 139, 1479–1486.
[8]  McCawley, MA; Kent, MS; Berakis, MT. Ultrafine beryllium number concentration as a Possible metric for chronic beryllium disease risk. Appl. Occup. Environ. Hyg.?2001, 16, 631–638.
[9]  Stefaniak, AB; Hoover, MD; Day, GA; Dickerson, RM; Peterson, EJ; Kent, MS; Schuler, CR; Breysse, PN; Scripsick, RC. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. Environ. Monit.?2004, 6, 523–532.
[10]  Tinkle, SS; Antonini, JM; Rich, BA; Roberts, JR; Salmen, R; DePree, K; Adkins, EJ. Skin as a route of exposure and sensitization for chronic beryllium disease. Environ. Health Perspect.?2003, 111, 1202–1208.
[11]  Henneberger, PK; Goe, SK; Miller, WE; Doney, B; Groce, DW. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J. of Occup. and Environ. Hyg.?2004, 1, 648–659.
[12]  Kreiss, K; Day, GA; Schuler, CR. Beryllium: A Modern Industrial Hazard. Annu. Rev. Public Health?2007, 28, 259–277.
[13]  Richeldi, L; Sorrentino, R; Saltini, C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science?, 262, 242–244.
[14]  Deubner, DC; Goodman, M; Iannuzzi, J. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): Preliminary analysis of the ongoing workforce survey. Appl. Occup. Environ. Hyg.?2001, 16, 521–526.
[15]  Middleton, DC; Lewin, MD; Kowalski, PJ; Cox, SS; Kleinbaum, D. The BeLPT: Algorithms and interpretations. Am. J. Ind. Med.?2006, 49, 36–44.
[16]  Stange, AW; Furman, FJ; Hilmas, DE. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance. Am. J. Ind. Med.?2004, 46, 453–462.
[17]  Middleton, DC; Fink, J; Kowalski, PJ; Lewin, MD; Sinks, T. Optimizing the BeLPT criteria for beryllium sensitization. Am. J. Ind. Med.?2008, 51, 166–172.
[18]  NRC (National Research Council) of the National Academies. Managing health effects of beryllium exposure. The National Academies Press: Washington, DC, USA, 2008; p. 168.
[19]  Donovan, EP; Kolanz, ME; Galbraith, DA; Chapman, PS; Paustenbach, DJ. Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program. Int. Arch. Occup. Environ. Health.?2007, 81, 165–178.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133